Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer.

Saved in:
Bibliographic Details
Title: Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer.
Authors: Schieber T; Pharmacy Department, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH. Electronic address: timothy.schieber@osumc.edu., Steele S; Pharmacy Department, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH; The Ohio State University, School of Pharmacy, Columbus, OH., Collins S; Pharmacy Department, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Berger M; Pharmacy Department, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Fleming M; Pharmacy Department, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., McLaughlin E; Department of Statistics, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Sudheendra P; Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Vargo C; Pharmacy Department, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH.
Source: Clinical breast cancer [Clin Breast Cancer] 2023 Aug; Vol. 23 (6), pp. 658-663. Date of Electronic Publication: 2023 May 24.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0666
DOI:10.1016/j.clbc.2023.05.009